Hypertension is an important risk factor for cardiovascular morbidity and mortality and for
events such as myocardial infarction, stroke, heart failure and chronic kidney disease and is …

Neuropeptide Y (NPY) is a 36-amino acid peptide belonging to the pancreatic polypeptide
family that has marked and diverse biological activity across species. NPY originally was …

Muscle nerve sympathetic activity (MSA) was recorded during wakefulness in 11 patients
with obstructive sleep apnea (OSA) and in 9 sex-and age-matched healthy control subjects …

Objective: To study in parallel the outflow of the sympathetic nervous system (SNS) and the
hypothalamic-pituitary adrenal (HPA) axis tone in systemic lupus erythematosus (SLE) and …

With average life expectancy rising greatly, the incidence rate of arteriosclerotic
cardiovascular disease (ASCVD) has significantly increased. The heart disease has now …

High levels of sympathetic drive in several cardiovascular diseases including
postmyocardial infarction, chronic congestive heart failure and hypertension are reinforced …

Neuropeptides in the lung occur in neurons, neuroendocrine and inflammatory cells. Their
widespread distribution and physiological effects suggest that they may play important roles …

Since the sympathetic nervous system has been shown to exert a trophic influence on
vascular smooth muscle cells (SMC), we studied the growth regulating effects of …

It has been suggested that neuropeptide Y (NPY) is involved in the pathophysiology of
depression. Plasma peptide-rich fraction from patients with major depressive disorder and …

Hypertension-induced left ventricular hypertrophy (LVH), along with ischemic heart disease,
result in LV remodeling as part of a continuum that often leads to congestive heart failure …